生物信息学分析关键基因和潜在的治疗药物,用于慢性病中的血管化
Guojie Ye1,2, Tengfei Liu1,2, Chunhua Ding1,2
1Cardiac Department, Aerospace Center Hospital, Beijing, China.
Nucleosides, nucleotides & nucleic acids
|November 18, 2024
概括
慢性病 (CKD) 的血管化涉及复杂的分子机制. 这项研究确定了关键的基因和潜在的药物,如Enavatuzumab,用于治疗这种常见的CKD并发症.
科学领域:
- 生物化学 生化学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 血管化是慢性病 (CKD) 的常见并发症.
- 在CKD中血管化的精确分子基础和有效的治疗策略尚未完全理解.
研究的目的:
- 通过生物信息分析阐明CKD血管化的分子机制.
- 确定潜在的治疗药物来管理慢性病患者的血管化.
主要方法:
- 基因本体学 (GO) 标注和通路丰富的生物信息分析.
- 识别常见的基因,丰富的GO术语以及信号通路 (KEGG,REACTOME,BIOCARTA).
- 选潜在的治疗药物,针对已识别的分子通路.
主要成果:
- 确定了76个常见的基因,181个丰富的GO注释和多个丰富的途径.
- 分离了五个关键基因:PSMC5,TNFSF11,TNFRSF11A,TNFRSF12A,以及ICAM1. 这些基因都被分离出来.
- 发现了五种潜在的治疗药物:ENAVATUZUMAB,DENOSUMAB,ALICAFORSEN,BI-505和ENLIMOMAB PEGOL. 这三种药物被认为具有治疗效果.
结论:
- 这项研究提供了对CKD血管化的全面生物信息分析.
- 已经确定了关键基因和潜在的治疗点,为治疗提供了新的途径.
- 需要进一步的实验验证,以确认已识别的药物的治疗疗效.
相关概念视频
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
3
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
3
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K


